KR102045192B1 - Energy drink liquid - Google Patents
Energy drink liquid Download PDFInfo
- Publication number
- KR102045192B1 KR102045192B1 KR1020170150478A KR20170150478A KR102045192B1 KR 102045192 B1 KR102045192 B1 KR 102045192B1 KR 1020170150478 A KR1020170150478 A KR 1020170150478A KR 20170150478 A KR20170150478 A KR 20170150478A KR 102045192 B1 KR102045192 B1 KR 102045192B1
- Authority
- KR
- South Korea
- Prior art keywords
- extract
- energy
- weight
- water
- present
- Prior art date
Links
- 235000015897 energy drink Nutrition 0.000 title claims abstract description 26
- 239000007788 liquid Substances 0.000 title claims abstract description 6
- 241000132536 Cirsium Species 0.000 claims abstract description 17
- 241000209020 Cornus Species 0.000 claims abstract description 14
- 235000013361 beverage Nutrition 0.000 claims abstract description 11
- 239000000284 extract Substances 0.000 claims description 50
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 27
- 239000000243 solution Substances 0.000 claims description 13
- 235000000346 sugar Nutrition 0.000 claims description 11
- 239000012141 concentrate Substances 0.000 claims description 10
- 240000004784 Cymbopogon citratus Species 0.000 claims description 8
- 235000017897 Cymbopogon citratus Nutrition 0.000 claims description 8
- 240000006079 Schisandra chinensis Species 0.000 claims description 8
- 235000008422 Schisandra chinensis Nutrition 0.000 claims description 8
- 229910052680 mordenite Inorganic materials 0.000 claims description 8
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 claims description 7
- 240000000797 Hibiscus cannabinus Species 0.000 claims description 7
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 claims description 7
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 claims description 7
- 235000020687 goji berry extract Nutrition 0.000 claims description 7
- 239000000052 vinegar Substances 0.000 claims description 6
- 235000021419 vinegar Nutrition 0.000 claims description 6
- 241001107116 Castanospermum australe Species 0.000 claims description 5
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 5
- 235000021279 black bean Nutrition 0.000 claims description 5
- 239000012153 distilled water Substances 0.000 claims description 5
- 239000011777 magnesium Substances 0.000 claims description 5
- 229910052749 magnesium Inorganic materials 0.000 claims description 5
- 239000007864 aqueous solution Substances 0.000 claims description 4
- 239000003610 charcoal Substances 0.000 claims description 4
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 4
- 239000000843 powder Substances 0.000 claims description 4
- 229910052761 rare earth metal Inorganic materials 0.000 claims description 4
- 150000002910 rare earth metals Chemical class 0.000 claims description 4
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 abstract description 34
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 abstract description 17
- 229960001948 caffeine Drugs 0.000 abstract description 17
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 abstract description 17
- 229930003935 flavonoid Natural products 0.000 abstract description 9
- 150000002215 flavonoids Chemical class 0.000 abstract description 9
- 235000017173 flavonoids Nutrition 0.000 abstract description 9
- 230000003078 antioxidant effect Effects 0.000 abstract description 8
- 150000008442 polyphenolic compounds Chemical class 0.000 abstract description 7
- 235000013824 polyphenols Nutrition 0.000 abstract description 7
- 239000007787 solid Substances 0.000 abstract description 6
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 abstract description 4
- 239000000796 flavoring agent Substances 0.000 abstract description 3
- 235000019634 flavors Nutrition 0.000 abstract description 3
- 230000007760 free radical scavenging Effects 0.000 abstract description 3
- 239000003086 colorant Substances 0.000 abstract 1
- 206010016256 fatigue Diseases 0.000 description 12
- 230000000052 comparative effect Effects 0.000 description 10
- 235000019640 taste Nutrition 0.000 description 8
- 230000000694 effects Effects 0.000 description 7
- 229910052500 inorganic mineral Inorganic materials 0.000 description 7
- 239000011707 mineral Substances 0.000 description 7
- 239000003921 oil Substances 0.000 description 7
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 6
- 238000011156 evaluation Methods 0.000 description 6
- 229940105022 spearmint extract Drugs 0.000 description 5
- 239000003963 antioxidant agent Substances 0.000 description 4
- 235000006708 antioxidants Nutrition 0.000 description 4
- 235000019658 bitter taste Nutrition 0.000 description 4
- 230000035622 drinking Effects 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 238000011084 recovery Methods 0.000 description 4
- 230000001953 sensory effect Effects 0.000 description 4
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 3
- 229930003268 Vitamin C Natural products 0.000 description 3
- 238000002835 absorbance Methods 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 230000034994 death Effects 0.000 description 3
- 231100000517 death Toxicity 0.000 description 3
- 235000013399 edible fruits Nutrition 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 238000010025 steaming Methods 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 239000011718 vitamin C Substances 0.000 description 3
- 235000019154 vitamin C Nutrition 0.000 description 3
- YEFOAORQXAOVJQ-UHFFFAOYSA-N wuweizischun A Natural products C1C(C)C(C)(O)CC2=CC(OC)=C(OC)C(OC)=C2C2=C1C=C(OC)C(OC)=C2OC YEFOAORQXAOVJQ-UHFFFAOYSA-N 0.000 description 3
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 208000019901 Anxiety disease Diseases 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 244000241838 Lycium barbarum Species 0.000 description 2
- 235000015459 Lycium barbarum Nutrition 0.000 description 2
- LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 description 2
- RKFAZBXYICVSKP-AATRIKPKSA-N alpha-asarone Chemical compound COC1=CC(OC)=C(\C=C\C)C=C1OC RKFAZBXYICVSKP-AATRIKPKSA-N 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 235000010208 anthocyanin Nutrition 0.000 description 2
- 229930002877 anthocyanin Natural products 0.000 description 2
- 239000004410 anthocyanin Substances 0.000 description 2
- 150000004636 anthocyanins Chemical class 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000036506 anxiety Effects 0.000 description 2
- 230000037007 arousal Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 244000309464 bull Species 0.000 description 2
- 238000004364 calculation method Methods 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000003792 electrolyte Substances 0.000 description 2
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 230000003908 liver function Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000003340 mental effect Effects 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 238000001179 sorption measurement Methods 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- PEYUIKBAABKQKQ-AFHBHXEDSA-N (+)-sesamin Chemical compound C1=C2OCOC2=CC([C@H]2OC[C@H]3[C@@H]2CO[C@@H]3C2=CC=C3OCOC3=C2)=C1 PEYUIKBAABKQKQ-AFHBHXEDSA-N 0.000 description 1
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- GOLORTLGFDVFDW-UHFFFAOYSA-N 3-(1h-benzimidazol-2-yl)-7-(diethylamino)chromen-2-one Chemical compound C1=CC=C2NC(C3=CC4=CC=C(C=C4OC3=O)N(CC)CC)=NC2=C1 GOLORTLGFDVFDW-UHFFFAOYSA-N 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 241000208173 Apiaceae Species 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 206010012289 Dementia Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 239000005770 Eugenol Substances 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 208000004547 Hallucinations Diseases 0.000 description 1
- 235000015928 Hibiscus cannabinus Nutrition 0.000 description 1
- OVSQVDMCBVZWGM-SJWGPRHPSA-N Hyperin Natural products O[C@H]1[C@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-SJWGPRHPSA-N 0.000 description 1
- FVQOMEDMFUMIMO-UHFFFAOYSA-N Hyperosid Natural products OC1C(O)C(O)C(CO)OC1OC1C(=O)C2=C(O)C=C(O)C=C2OC1C1=CC=C(O)C(O)=C1 FVQOMEDMFUMIMO-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- 235000015468 Lycium chinense Nutrition 0.000 description 1
- 244000024873 Mentha crispa Species 0.000 description 1
- 235000014749 Mentha crispa Nutrition 0.000 description 1
- 208000000112 Myalgia Diseases 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010029216 Nervousness Diseases 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- IOVCWXUNBOPUCH-UHFFFAOYSA-M Nitrite anion Chemical compound [O-]N=O IOVCWXUNBOPUCH-UHFFFAOYSA-M 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 244000131316 Panax pseudoginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000032140 Sleepiness Diseases 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 229910021536 Zeolite Inorganic materials 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 125000000218 acetic acid group Chemical group C(C)(=O)* 0.000 description 1
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 1
- 229960004373 acetylcholine Drugs 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 230000004596 appetite loss Effects 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 235000019606 astringent taste Nutrition 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 238000003287 bathing Methods 0.000 description 1
- RKFAZBXYICVSKP-UHFFFAOYSA-N beta- asarone Natural products COC1=CC(OC)=C(C=CC)C=C1OC RKFAZBXYICVSKP-UHFFFAOYSA-N 0.000 description 1
- RKFAZBXYICVSKP-WAYWQWQTSA-N beta-asarone Chemical compound COC1=CC(OC)=C(\C=C/C)C=C1OC RKFAZBXYICVSKP-WAYWQWQTSA-N 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 230000008468 bone growth Effects 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 238000010000 carbonizing Methods 0.000 description 1
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 1
- 235000005487 catechin Nutrition 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 210000003710 cerebral cortex Anatomy 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 150000001805 chlorine compounds Chemical class 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 229950001002 cianidanol Drugs 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- PEYUIKBAABKQKQ-UHFFFAOYSA-N epiasarinin Natural products C1=C2OCOC2=CC(C2OCC3C2COC3C2=CC=C3OCOC3=C2)=C1 PEYUIKBAABKQKQ-UHFFFAOYSA-N 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 229960002217 eugenol Drugs 0.000 description 1
- 230000002964 excitative effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 229940074391 gallic acid Drugs 0.000 description 1
- 235000004515 gallic acid Nutrition 0.000 description 1
- 229910052732 germanium Inorganic materials 0.000 description 1
- GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical compound [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 239000008233 hard water Substances 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000010224 hepatic metabolism Effects 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 208000019017 loss of appetite Diseases 0.000 description 1
- 235000021266 loss of appetite Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 208000013465 muscle pain Diseases 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 229960002715 nicotine Drugs 0.000 description 1
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 description 1
- 150000002840 non-reducing disaccharides Chemical class 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 150000002892 organic cations Chemical class 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 210000005037 parasympathetic nerve Anatomy 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 229940107700 pyruvic acid Drugs 0.000 description 1
- OVSQVDMCBVZWGM-DTGCRPNFSA-N quercetin 3-O-beta-D-galactopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-DTGCRPNFSA-N 0.000 description 1
- BBFYUPYFXSSMNV-UHFFFAOYSA-N quercetin-7-o-galactoside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC(O)=C2C(=O)C(O)=C(C=3C=C(O)C(O)=CC=3)OC2=C1 BBFYUPYFXSSMNV-UHFFFAOYSA-N 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- YEFOAORQXAOVJQ-RZFZLAGVSA-N schisandrol a Chemical compound C1[C@H](C)[C@@](C)(O)CC2=CC(OC)=C(OC)C(OC)=C2C2=C1C=C(OC)C(OC)=C2OC YEFOAORQXAOVJQ-RZFZLAGVSA-N 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- VRMHCMWQHAXTOR-CMOCDZPBSA-N sesamin Natural products C1=C2OCOC2=CC([C@@H]2OC[C@@]3(C)[C@H](C=4C=C5OCOC5=CC=4)OC[C@]32C)=C1 VRMHCMWQHAXTOR-CMOCDZPBSA-N 0.000 description 1
- 230000037321 sleepiness Effects 0.000 description 1
- 235000019614 sour taste Nutrition 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 231100000200 toxicological information Toxicity 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- -1 triterpenoid glycosides Chemical class 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 230000003313 weakening effect Effects 0.000 description 1
- 239000010457 zeolite Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/38—Other non-alcoholic beverages
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/70—Clarifying or fining of non-alcoholic beverages; Removing unwanted matter
- A23L2/72—Clarifying or fining of non-alcoholic beverages; Removing unwanted matter by filtration
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/33—High-energy foods and drinks, sports drinks
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/21—Plant extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/14—Extraction
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- Botany (AREA)
- Mycology (AREA)
- Non-Alcoholic Beverages (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
본 발명은 에너지 음료액에 관한 것으로, 보다 상세하게는 카페인을 함유하지 않으면서도 지역 특산물인 석창포, 오갈피, 엉겅퀴, 산수유 등을 이용하여 카페인이 함유된 에너지 음료에 버금가는 가용성 고형분과 색도 및 맛을 갖도록 하여 소비자의 기호도를 충족시키면서 특히, 폴리페놀과 플라보노이드 함량을 증대시켜 항산화활성(DPPH free radical scavenging activity)을 강화시킨 에너지 음료액에 관한 것이다.The present invention relates to an energy beverage, and more particularly, to soluble solids, colors, and flavors comparable to those of caffeine-containing energy drinks using local special products such as Seokchangpo, Ogalpi, thistle, and cornus oil. In particular, the present invention relates to an energy drink liquid having enhanced polyphenol and flavonoid content and enhanced antioxidant activity (DPPH free radical scavenging activity) while satisfying consumer's preference.
Description
본 발명은 에너지 음료액에 관한 것으로, 보다 상세하게는 지역 특산물인 석창포, 오갈피, 엉겅퀴, 산수유 등을 이용하여 카페인이 함유된 에너지 음료에 버금가는 색도 및 맛을 갖도록 하여 소비자의 기호도를 충족시키면서 특히, 폴리페놀과 플라보노이드 함량을 증대시켜 항산화활성(DPPH free radical scavenging activity)을 강화시킨 에너지 음료액에 관한 것이다.The present invention relates to an energy drink, and more particularly, to satisfy the taste of the consumer by having a color and taste comparable to an energy drink containing caffeine using local special products such as Seokchangpo, Ogalpi, thistle, cornus oil, etc. The present invention relates to an energy drink liquid having enhanced antioxidant capacity (DPPH free radical scavenging activity) by increasing polyphenol and flavonoid content.
알려진 바와 같이, 에너지 음료(energy drink)란 운동이나 노동 등으로 인하여 체내에서 빠져나간 수분과 전해질을 보충해주어 피로회복을 돕는 기능성 음료를 말한다.As is known, energy drinks refer to functional drinks that replenish moisture and electrolytes that escape from the body due to exercise or labor, thereby helping to recover from fatigue.
즉, 육체 피로시의 영양 보급 등을 목적으로 시중에 판매되고 있는 음료로서, 어쩌다가 한 번만 마시면 괜찮지만 과량으로 음용할 경우 암·심장병·순환계 질환을 유발하기도 하니 조심해야 한다.In other words, it is a commercially available drink for the purpose of nourishment during physical fatigue, and it is okay to drink it only once, but if you drink it in excess, it may cause cancer, heart disease, and circulatory diseases.
특히 노약자, 임산부, 어린이 등 카페인 섭취에 예민한 사람은 음용을 자제해야 하며, 대표적인 시판용 에너지 음료로는 레드불, 몬스터 에너지, 핫식스 등이 있다.In particular, those who are sensitive to caffeine intake such as the elderly, pregnant women and children should refrain from drinking. Typical commercial energy drinks include Red Bull, Monster Energy, and Hot Six.
다만, 당을 비롯하여 나트륨, 칼륨, 마그네슘 등의 무기질과, 비타민 C를 함유한 에너지 음료의 경우에는 체내에서 빠져나간 수분과 전해질을 보충하여 피로회복을 돕기 때문에 운동선수들의 경우 건강에 해로운 단백 동화 스테로이드 대신에 필요한 영양소와 에너지를 빠르고 간편하게 얻을 수 있어 선호되는 것으로 보인다.However, in the case of energy drinks containing sugars, minerals such as sodium, potassium, and magnesium, and vitamin C, it helps to relieve fatigue by replenishing water and electrolytes that escape from the body. Instead, they seem to be preferred because they can quickly and easily get the nutrients and energy they need.
그런데, 최근 중·고생들과 같은 청소년들 사이에서는 특히, 시험기간에 카페인에 의한 각성효과가 높다는 이유로 에너지 음료가 과다하게 음용되고 있으며, 이 기간내 매출액이 평상시보다 10배 이상 급격히 상승하는 것으로 파악되고 있다.However, among teenagers such as middle and high school students, energy drinks are excessively consumed because of the high arousal effect of caffeine, especially during the trial period, and sales are estimated to rise more than 10 times more rapidly than usual. have.
이처럼 에너지 음료는 피로회복에 좋은 성분을 많이 함유하고 있음에도 불구하고, 성인이 아닌 청소년들의 경우 카페인 함량이 많다는 것이 문제가 된다.Even though energy drinks contain a lot of good ingredients for fatigue recovery, it is a problem that adolescents, not adults, have a high content of caffeine.
원래 카페인은 대뇌피질의 감각중추를 흥분시키는 작용을 하며, 또 신진대사를 자극해 피로를 줄이고 정신을 각성시켜 일시적으로 졸음을 막아주는 효과가 있다.Originally, caffeine acts to excite the cerebral cortex's sensory centers, and stimulates metabolism to reduce fatigue and arouse the mind to temporarily stop sleepiness.
하지만, 카페인을 과다하게 섭취하면 도리어 짜증, 불안, 신경과민, 불면, 두통 등 다양한 신체적 정신적 증상이 나타날 수 있다. 특히 어린이나 청소년들에게는 성인보다 부작용이 더 심하게 나타난다. However, excessive amounts of caffeine can lead to a variety of physical and mental symptoms, including irritability, anxiety, nervousness, insomnia, and headaches. In particular, children and adolescents have more serious side effects than adults.
즉, 카페인을 지나치게 많이 섭취할 경우 칼슘 공급에 문제가 일어나는데, 이 경우 뼈의 성장이 지체되고 성인이 된 후 골다공증을 앓을 수도 있고, 심하면 위통, 현기증, 식욕 감퇴 뿐만 아니라 심장발작까지 생길 수 있다.In other words, excessive intake of caffeine causes a problem in calcium supply, in which case bone growth may be delayed and adult osteoporosis may occur, and severe stomach pain, dizziness, loss of appetite, and heart attacks may occur.
때문에 식약청에서는 카페인 권장 섭취량을 하루에 성인 400mg, 임신부 300mg, 어린이는 몸무게 1kg당 2.5mg 이하로 제한할 것을 권고하고 있다.Therefore, the FDA recommends limiting the recommended intake of caffeine to 400 mg per day for adults, 300 mg for pregnant women and 2.5 mg per kilogram of body weight.
그런데, 에너지 음료에는 한 캔당 80mg 정도의 카페인이 첨가돼 있어 다른 음료와 섞어 마시게 되면 그야말로 몸에 카페인 폭탄을 투하하는 격이 된다.However, energy drinks contain about 80mg of caffeine per can, so if you mix it with other drinks, you're really going to drop a caffeine bomb on your body.
카페인의 과섭취에 따른 사례로, 시드니 의대와 뉴사우스 웨일스 독극물정보센터 연구진은 2012년 1월 호주 의학저널에서 에너지 음료로 인한 부작용 사례가 2004년 12건에서 2010년 65건으로 급증했다고 지적했으며, 이 가운데 최소 128명이 심장 두근거림, 불안, 소화불량 등의 증세로 입원했고, 입원 환자 20명은 발작, 환각 등의 증상도 보인 것으로 보고한 바 있다.In the case of caffeine ingestion, researchers at the Sydney Medical and New South Wales Toxicological Information Center pointed out that in January 2012, Australian medical journals reported that side effects from energy drinks surged from 12 in 2004 to 65 in 2010. At least 128 of them were hospitalized with heart palpitations, anxiety and indigestion, and 20 patients were reported to have seizures and hallucinations.
또한, 프랑스에서는 아일랜드 출신 운동선수가 에너지 음료 레드불을 과다섭취해 사망한 사건을 계기로 판매허가가 나지 않은 사례가 있고, 미국에서는 14세 학생이 480㎎의 카페인이 들어 있는 '몬스터 에너지'라는 제품 2캔을 마신 뒤 심장 부정맥으로 사망하는 등 에너지 음료와 관련 있어 보이는 사망 사례가 늘고 있는 실정이다.
In France, there was a case where an Irish athlete was not allowed to sell due to the death of excessive energy drink Red Bull. In the United States, a 14-year-old student called `` Monster Energy, '' which contains 480 mg of caffeine. There are an increasing number of deaths associated with energy drinks, such as death from cardiac arrhythmias after drinking two cans of the product.
본 발명은 상술한 바와 같은 종래 기술상의 제반 문제점들을 감안하여 이를 해결하고자 창출된 것으로, 지역 특산물인 석창포, 오갈피, 엉겅퀴, 산수유 등을 이용하여 카페인이 함유된 에너지 음료에 버금가는 색도 및 맛을 갖도록 하여 소비자의 기호도를 충족시킬 수 있는 에너지 음료액을 제공함에 그 주된 목적이 있다.The present invention was created in view of the above-described problems in the prior art, and has been created to solve this problem, so as to have a color and taste comparable to an energy drink containing caffeine using local special products such as Seokchangpo, Ogalpi, thistle, cornus oil, etc. The main purpose is to provide an energy drink that can meet the consumer's preference.
본 발명은 상기한 목적을 달성하기 위한 수단으로, 에너지 음료액에 있어서, 음료액 150㎖를 기준으로, 석창포 추출액 12㎖와, 오갈피 추출액 14㎖와, 엉겅퀴 추출액 12㎖와, 오미자 추출액 8㎖와, 매실 농축액 0.1㎖와, 산수유 추출액 12㎖와, 구기자 추출액 14㎖와, 설탕 18g과, 신선초즙 3㎖와, 끄라차이담 추출액 3㎖와, 트레할로스 수용액 2㎖와, 레몬그라스액 1.5㎖ 및 나머지 물로 이루어진 것을 특징으로 하고, 상기 석창포 추출액은 석창포의 생잎, 생줄기 및 꽃을 항아리에 넣고, 검은콩을 함께 넣은 상태에서 중탕하여 추출된 것을 특징으로 하는 에너지 음료액을 제공한다.
또한, 상기 물은 증류수를 활성 모데나이트 25중량%와, 마그네슘 4중량%와, 이방성 희토류 자석분말 10중량%와, 케나프 숯 1.5중량% 및 나머지 천연 모데나이트로 이루어진 여과재에 여과시킨 것임을 특징으로 한다.The present invention is a means for achieving the above object, in the energy drink liquid, based on 150 ml of the beverage, 12 ml of spearmint extract, 14 ml of this extract, 12 ml of thistle extract, 8 ml of Schisandra chinensis extract and 0.1 ml of plum concentrate, 12 ml of cornus oil extract, 14 ml of goji berry extract, 18 g of sugar, 3 ml of fresh vinegar juice, 3 ml of Kratchaidam extract, 2 ml of trehalose solution, 1.5 ml of lemongrass solution, and the rest. Characterized in that it consists of water, the changchangpo extract provides energy drinks, characterized in that extracted by placing the green leaves, raw stems and flowers of the changchangpo in a jar, and bathed in a state in which black beans are put together.
In addition, the water is filtered by distilled water in a filter medium consisting of 25% by weight of active mordenite, 4% by weight of magnesium, 10% by weight of anisotropic rare earth magnet powder, 1.5% by weight of kenaf charcoal and the remaining natural mordenite do.
삭제delete
삭제delete
삭제delete
삭제delete
본 발명에 따르면, 지역 특산물인 석창포, 오갈피, 엉겅퀴, 산수유 등을 이용하여 카페인이 함유된 에너지 음료에 버금가는 색도 및 맛을 갖도록 하여 소비자의 기호도를 충족시키는 효과를 얻을 수 있다.According to the present invention, by using local special products such as Seokchangpo, Ogalpi, thistle, cornus milk, etc., it is possible to have the color and taste comparable to an energy drink containing caffeine, thereby achieving the effect of satisfying the taste of consumers.
이하에서는, 본 발명에 따른 바람직한 실시예를 보다 상세하게 설명하기로 한다.Hereinafter, a preferred embodiment according to the present invention will be described in more detail.
본 발명 설명에 앞서, 이하의 특정한 구조 내지 기능적 설명들은 단지 본 발명의 개념에 따른 실시예를 설명하기 위한 목적으로 예시된 것으로, 본 발명의 개념에 따른 실시예들은 다양한 형태로 실시될 수 있으며, 본 명세서에 설명된 실시예들에 한정되는 것으로 해석되어서는 아니된다.Prior to the description of the present invention, the following specific structures or functional descriptions are merely illustrated for the purpose of describing embodiments according to the inventive concept, and the embodiments according to the inventive concept may be implemented in various forms, It should not be construed as limited to the embodiments described herein.
또한, 본 발명의 개념에 따른 실시예는 다양한 변경을 가할 수 있고 여러 가지 형태를 가질 수 있으므로, 본 발명의 사상 및 기술 범위에 포함되는 모든 변경물, 균등물 내지 대체물을 포함하는 것으로 이해되어야 한다.In addition, the embodiment according to the concept of the present invention may be variously modified and may have various forms, it should be understood to include all modifications, equivalents, or substitutes included in the spirit and scope of the present invention. .
본 발명에 따른 에너지 음료액은 150㎖를 기준으로, 석창포 추출액 12㎖와, 오갈피 추출액 14㎖와, 엉겅퀴 추출액 12㎖와, 오미자 추출액 8㎖와, 매실 농축액 0.1㎖와, 산수유 추출액 12㎖와, 구기자 추출액 14㎖와, 설탕 18g 및 나머지 물로 이루어진다.The energy drink according to the present invention is based on 150ml, 12ml of spearmint extract, 14ml of ogalpi extract, 12ml of thistle extract, 8ml of Schisandra chinensis extract, 0.1ml of Plum Concentrate, 12ml of Cornus extract, 14 ml of wolfberry extract, 18 g of sugar and the remaining water.
이때, 설탕 18g은 18㎖로 환산되어 사용된 것이다.At this time, 18g of sugar is used in terms of 18ml.
예컨대, g은 질량 단위이고, ㎖는 부피 단위로서 서로 대등한 환산관계에 있지 않지만, 통상 물 1ℓ에 해당하는 물의 부피가 1kg과 같기 때문에 1g에 해당하는 부피는 1㎖라고 보고 산정한 것이다.For example, g is a mass unit, and ml is a volume unit, which is not in equivalent relationship with each other. However, since a volume of water corresponding to 1 liter of water is equal to 1 kg, the volume corresponding to 1 g is calculated as 1 ml.
여기에서, 석창포 추출액은 5년 이상된 석창포의 생잎과 줄기 및 꽃을 검은콩과 함께 넣고 중탕하여 추출된다.Here, the extract of Seokchang-po is extracted by placing the raw leaves, stems, and flowers of Seokchangpo over 5 years with black beans and bathing them.
통상, 석창포는 말린 줄기와 뿌리를 차로 음용하지만, 본 발명에서는 뿌리는 사용하지 않고 반드시 말리지 않은 생잎과 줄기 및 꽃을 사용해야 한다. 또한, 5년 미만의 경우에는 약리효과가 떨어지는 것으로 보고되어 있기 때문에 5년 이상의 것을 사용함이 바람직하다.Normally, the spearmint is drunk with dried stems and roots, but in the present invention, roots should not be used, and fresh leaves, stems, and flowers that are not necessarily dried should be used. In addition, if less than 5 years is reported that the pharmacological effect is poor, it is preferable to use more than 5 years.
특히, 석창포의 생잎과 줄기 및 꽃에 함유된 정유 성분인 알파-아사론(α-asarone)과 베타-아사론(β-asarone) 및 오이게놀(eugenol) 성분의 추출을 원활하게 하여 카페인을 포함하지 않고도 신경을 안정화시킬 수 있어 집중력을 높이도록 유도할 수 있다.In particular, caffeine is smoothed by smoothly extracting alpha-asarone, β-asarone, and eugenol, which are essential oils contained in raw leaves, stems, and flowers of Seokchangpo. The nerves can be stabilized without inclusion, leading to increased concentration.
더구나, 레시틴 성분이 풍부한 검은콩을 함께 넣어 추출액을 만들도록 함으로써 석창포의 쓴맛을 약화시키면서 신체의 아세틸콜린을 보조적으로 도와주도록 하여 인체 건강 증진에 기여하도록 하여야 한다.Moreover, black beans rich in lecithin should be added together to make extracts, so as to help the body's acetylcholine, while weakening the bitter taste of Seokchangpo.
이를 위한 중탕 방법은 300㎖의 항아리에 석창포의 생잎과 줄기 및 꽃을 넣고, 300㎖의 항아리 기준으로 검은콩 12알을 함께 넣은 뒤 기름종이로 1차 밀폐 후 기름종이 위에 다시 삼베로 입구를 막은 상태에서 물이 채워진 용기에 항아리를 넣고 용기의 뚜껑을 닫은 상태에서 100℃의 온도로 1시간 30분 가열 중탕하여 얻은 추출액을 걸려 사용한다.For the bath method, put raw leaves, stems, and flowers of Seokchangpo in 300ml jars, put 12 black beans together in 300ml jars, and seal the inlet with oil paper after first sealing with oil paper. Put the jar in a container filled with water in the state, and use the extract obtained by heating and boiling for 1 hour and 30 minutes at a temperature of 100 ° C. with the lid of the container closed.
이때, 기름종이를 사용하는 이유는 정유에 함유된 알파-아사론과 베타-아사론의 휘발을 최대한 억제하기 위함이다.At this time, the reason why the oil paper is used is to suppress the volatilization of alpha-aron and beta-aron in the essential oil.
때문에, 본 발명의 중탕방식을 일반적인 중탕과는 개념이 완전히 다른 것이다.Therefore, the concept of the present invention is completely different from the general bath.
다만, 본 발명에 따른 석창포 추출액은 20㎖를 초과하여 사용하지 말아야 하는데, 이는 농축과 같은 과량 첨가시 잠재적 독성성분에 의한 오심, 구토, 간대사를 나쁘게 할 수 있기 때문이다.However, the extract of Seokchangpo according to the present invention should not be used in excess of 20ml, because it may worsen nausea, vomiting and hepatic metabolism due to potential toxic components when excessive addition such as concentration.
이와 같은 이유로 석창포의 생뿌리나 생잎의 직접 복용은 가급적 금지해야 한다. 그럼에도 불구하고, 본 발명에서는 생잎과 생줄기를 사용하되, 효능 향상을 위해 독특한 중탕 방식으로 추출액을 만들어 사용하도록 한 독창적인 아이디어를 적용하고 있다.For this reason, the direct use of raw roots or leaves of Seokchangpo should be prohibited. Nevertheless, the present invention applies the original idea to use the raw leaves and stems, but to make the extract in a unique bath method to improve efficacy.
아울러, 오갈피 추출액은 오갈피 나무의 뿌리와 줄기의 껍질을 탕약(달여)하여 체로 걸러 얻는다.In addition, the extract of Aggalpi is obtained by sifting the bark of the root and stem of the Agalpi tree (decoction).
오가피는 맵고 쓰지만 독성이 없는 천연약재로서, 특히 쿠마린과 시린진, 세사민, 하이페린이 함유되어 있어 항피로작용과 진정작용, 신경계 조절을 통한 흥분안정 효과가 있고, 트리테르페노이드계 배당체를 7종류나 함유하고 있어 나무인삼이라는 별명이 붙어 있는 약재 중 하나이다.Ogapi is a spicy, bitter, but non-toxic natural medicine. Especially, it contains coumarin, sirin, sesamin, and hyperin, which has anti-fatigue effect, sedation, and nervous system regulation. It also has triterpenoid glycosides. It is one of the medicines with the nickname of ginseng.
본 발명에서는 신경안정과 조절을 위해 첨가되며, 가용성 고형분 형성에 기여하게 된다.In the present invention is added for neurostable and control, and contributes to the formation of soluble solids.
그리고, 엉겅퀴 추출액은 엉겅퀴 뿌리를 증숙하여 추출한 것으로, 엉겅퀴는 비타민과 폴리페놀 및 플라보노이드가 풍부하게 함유되어 있어 체내 독소 해소, 항산화를 방지하여 만성피로를 획복하고 기력을 보강하는데 유용한 것으로 알려져 있다.In addition, thistle extract is extracted by steaming thistle root, thistle is rich in vitamins, polyphenols and flavonoids are known to be useful in relieving chronic fatigue and strengthening energy by preventing toxins, antioxidants in the body.
또한, 엉겅퀴도 본 발명에서 가용성 고형분 형성에 기여하게 된다.Thistle also contributes to the formation of soluble solids in the present invention.
아울러, 오미자 추출액은 오미자 열매를 압축하여 추출한 것으로, 오미자는 신맛, 단맛, 쓴맛, 짠맛, 매운맛 이렇게 5가지 맛이 섞여 있다고 해서 붙인 이름으로 알려져 있다.In addition, Schisandra chinensis extract is extracted by compressing Schisandra chinensis fruit, Schisandra chinensis is known by the name given to the mix of five flavors, such as sour, sweet, bitter, salty, spicy.
이때, 신맛은 기운을 북돋우며, 단맛은 석창포의 쓴맛을 가시게 하는데 활용되며, 오미자에 함유된 각종 무기질과 비타민 C는 강장효과가 있어 피로회복을 촉진하고, 면역력을 향상시키는 것으로 알려져 있어 체력저하를 막고, 신진대사(혈액순환)를 촉진하는데 도움을 준다.At this time, the sour taste cheers up, the sweetness is used to make bitter taste of Seokchangpo, and various minerals and vitamin C contained in Schisandra chinensis have a tonic effect, which is known to promote fatigue recovery and improve immunity. It helps to promote metabolism (blood circulation).
무엇보다도, 오미자는 플라보노이드 및 안토시아닌이 다량 함유되어 있어 항염증, 항산화 기능이 뛰어나기 때문에 본 발명의 경우 항산화 활성을 증대시키기 위해 첨가된다.Above all, Schizandra chinensis is added in order to increase the antioxidant activity in the present invention because it contains a large amount of flavonoids and anthocyanins and excellent anti-inflammatory and antioxidant function.
뿐만 아니라, 매실 농축액은 매실 열매를 농축한 것으로, 매실은 소화를 촉진하고, 시트르산이 풍부하여 피로 원인 물질은 젖산을 체외로 배출시켜 피로회복을 촉진하며, 피루브산이 함유되어 있어 간 기능 개선에도 효과가 있는 것으로 알려져 있는 바, 본 발명에서는 이러한 효능을 부가적으로 얻기 위해 첨가되며, 농축액이기 때문에 미량 첨가되어야 한다.In addition, the plum concentrate concentrates the fruit of the plum, the plum promotes digestion, and the rich citric acid, fatigue-causing substances discharge the lactic acid out of the body to promote fatigue recovery, and contains pyruvic acid to improve liver function It is known that there is, in the present invention is added to obtain this effect additionally, it should be added in trace amounts because it is a concentrate.
또한, 산수유 추출액은 산수유 열매를 증숙하여 추출한 것으로, 산수유에는 코르닌이 함유되어 있어 부교감신경 조절에 따른 흥분조절, 뇌 활성화에 따른 집중력 강화의 효과가 있으므로 본 발명에서는 이러한 효과를 얻기 위해 첨가된다.In addition, the cornus extract is extracted by steaming the fruit of the cornus, cornus contains cornine is added to obtain the effect in the present invention because it has the effect of strengthening the concentration according to the excitatory control, brain activation according to parasympathetic nerve control.
그리고, 구기자 추출액은 구기자 열매를 달여 만든 것으로, 구기자에는 비타민 C와 미네랄이 풍부하여 면역력을 강화시키며, 베타인이 함유되어 있어 손상된 간세포를 재생하고 촉진하여 피로회복을 빠르게 하는 특성이 있고, 판토텐산은 아세틸콜린 생성을 촉진하여 뇌를 활성화시키고 혈액순환을 촉진하므로 본 발명에서는 무 카페인 임에도 불구하고 집중력을 높이고 각성 효과를 부수적으로 얻을 수 있도록 하기 위해 첨가된다.And, goji berry extract is made by sweetening goji berry fruit, which is rich in vitamin C and minerals to strengthen immunity, and contains betaine, which has the characteristics of regenerating and promoting damaged liver cells to accelerate fatigue recovery, and pantothenic acid is acetyl. In order to promote choline production and activate the brain and promote blood circulation, in the present invention, it is added to increase concentration and additionally arousal effect despite being caffeine free.
아울러, 본 발명에서 사용되는 설탕은 당도(Brix)를 높이면서 석창포의 쓴맛을 희석시켜 맛을 좋게 하기 위해 첨가된다.In addition, the sugar used in the present invention is added to dilute the bitter taste of the changchangpo while increasing the sugar (Brix) to improve the taste.
또한, 본 발명에서 사용되는 물은 증류수를 활성 모데나이트 25중량%와, 마그네슘 4중량%와, 이방성 희토류 자석분말 10중량%와, 케나프 숯 1.5중량% 및 나머지 천연 모데나이트로 이루어진 여과재에 여과시킨 것을 사용한다.In addition, the water used in the present invention is filtered through distilled water in a filter material consisting of 25% by weight of active mordenite, 4% by weight of magnesium, 10% by weight of anisotropic rare earth magnet powder, 1.5% by weight of kenaf charcoal and the remaining natural mordenite. Use what you have.
이때, 활성 모데나이트는 통상 제올라이트로 알려진 광물로서 세공 속에 존재하는 양이온들은 수용액 중에서 다른 여러 가지 금속 및 유기 양이온으로 용이하게 교환되므로 이러한 성질을 이용하여 경수의 연수화를 위해 첨가된다.At this time, the active mordenite is a mineral commonly known as zeolite, and since the cations present in the pores are easily exchanged with various other metals and organic cations in aqueous solution, they are added for softening of hard water using this property.
또한, 마그네슘은 물과 반응하여 활성수소를 생성하고, 이를 통해 활성산소를 제거함으로써 인체유용도를 높이며, 잔류 염소화합물을 제거하는 역할을 담당하게 된다.In addition, magnesium reacts with water to produce active hydrogen, thereby increasing the usefulness of the human body by removing the active oxygen, and serves to remove residual chlorine compounds.
그리고, 이방성 희토 자석분말은 물 분자의 클러스터 미분화, 전기적 및 자기적 에너지 지속유지 기능을 담당하게 된다.In addition, the anisotropic rare earth magnet powder is responsible for the cluster micronization of the water molecules, electrical and magnetic energy sustaining functions.
뿐만 아니라, 케나프 숯은 케나프를 탄화시켜 만든 것으로서, 케나프(Hibiscus cannabinus L.)는 보통 섬유를 얻을 목적으로 인도, 방글라데시, 태국 등에서 재배되고 있는 양마(洋麻)로서 잎에는 칼슘이 우유의 4배가 함유되어 있고, 다량의 단백질과 비타민 및 철분이 함유되어 있으며, 활성산소의 작용을 억제하는 항산화물질이 다량 함유되어 있어 항염, 항바이러스 기능이 있는 것으로 보고되어 있다.In addition, Kenaf charcoal is made by carbonizing kenaf, and Kenaf (Hibiscus cannabinus L.) is a sheep that is usually cultivated in India, Bangladesh, and Thailand for the purpose of obtaining fiber. It contains 4 times of, contains a large amount of protein, vitamins and iron, and contains a large amount of antioxidants that inhibit the action of free radicals, has been reported to have anti-inflammatory and antiviral function.
아울러, 천연 모데나이트는 망상구조로 되어 있어 특히, 암모니아 흡착에 유용하고, 아질산염, 질산염, 물표면의 유막을 방지하며, 이끼 성장을 억제하는 유용한 광물이고, 나아가 이온교환기능에 의한 중금속 제거, 촉매작용에 의한 물분자 세분화, 흡착기능에 따른 냄새제거 및 연수화, 잔류 염소 제거를 위해 첨가된다.In addition, natural mordenite has a network structure, which is particularly useful for adsorption of ammonia, prevents nitrite, nitrate, and oil film on the surface of water, and is a useful mineral for inhibiting moss growth. It is added in order to subdivide water molecules by action, odor removal and softening by adsorption function, and removal of residual chlorine.
이와 같이 구성하게 되면, 본 발명은 폴리페놀과 플라보노이드 함량을 천연성분을 이용하여 일정 이상 유지시킬 수 있어 체내 항산화 활성을 강화시킬 수 있게 된다.When configured in this way, the present invention can maintain the polyphenol and flavonoid content by a certain amount or more by using natural ingredients to enhance the antioxidant activity in the body.
삭제delete
이에 더하여, 본 발명에서는 상기 음료액에 신선초즙 3㎖와, 끄라차이담 추출액 3㎖와, 트레할로스 수용액 2㎖ 및 레몬그라스액 1.5㎖를 더 첨가할 수 있다.In addition, in the present invention, 3 ml of fresh vinegar juice, 3 ml of Kratchaidam extract, 2 ml of trehalose aqueous solution and 1.5 ml of lemongrass solution may be further added to the beverage.
삭제delete
삭제delete
때문에, 이들 성분의 첨가량만큼 물을 더 적게 넣으면 된다. 즉, 음료액 150㎖를 구성하는 것이므로 상기 성분들의 첨가에 따라 그 만큼 물을 더 적게 넣어 총 150㎖의 음료액을 구성하면 되는 것이다.Therefore, what is necessary is just to add less water as the addition amount of these components. That is, 150 ml of the beverage is added, so that less water is added according to the addition of the components, so that a total of 150 ml of the beverage can be configured.
이때, 신선초즙을 구성하는 신선초는 명일엽, 선립초, 선삼초라고도 불리우는 미나리과의 식물로 여러해살이 초본이며, 플라보노이드 및 게르마늄이 다량 함유된 약초로 알려져 있으며, 특히 비타민 11종, 미네랄 13종이 함유되어 있어 체내에 쌓인 독성물질, 그 중에서도 니코틴 해독에 특효가 있고, 간 기능 개선, 당뇨 및 치매 예방에 효과가 우수한 것으로 보고되어 있는 바, 본 발명에서는 이러한 특성들이 함께 발현되도록 첨가 사용된다.At this time, the fresh vinegar constituting the fresh vinegar is a plant of the apiaceae, also called Myeongilyeop, Seoncho, Seonsamcho, and it is a perennial herb, known as a herb containing flavonoids and germanium, and contains 11 kinds of vitamins and 13 kinds of minerals. Toxic substances accumulated in the body, among them, are particularly effective in nicotine detoxification, and are reported to be effective in improving liver function, preventing diabetes, and dementia.
또한, 끄라차이담 추출액은 끄라차이담을 증숙한 후 추출한 것으로, 안토시아닌(anthocyanin)이 풍부하게 포함되어 있고, 그 외에도 폴리페놀, 아르기닌, 아연, 미네랄과 필수 아미노산을 풍부하게 포함하고 있다.In addition, the Kratchaidam extract is extracted after steaming the Kraichaidam, rich in anthocyanin (polyanol, arginine, zinc, minerals and essential amino acids in addition to the rich.
때문에, 지구력을 향상시키고 피로를 줄여주며 집중력을 향상시키고 혈액순환을 촉진해서 근육통을 줄여주며, 심신 안정과 혈압을 유지하는데 도움을 주도록 첨가된다.Because of this, it is added to improve endurance, reduce fatigue, improve concentration, promote blood circulation, reduce muscle pain, and help maintain physical and mental stability and blood pressure.
또한, 트레할로스 수용액은 트레할로스를 물에 녹인 것으로, 트레할로스는 2분자의 글루코스가 α-1, α-1 결합한 비환원성의 이당(二糖)으로 α-D-글루코피라노실 α-D-글루코피라노시드이다. 이는 감미성을 통해 음용시 맛을 좋게 하고, pH를 안정화시키게 된다.In addition, the aqueous trehalose solution is a solution of trehalose in water. Trehalose is a non-reducing disaccharide in which two molecules of glucose are combined with α-1 and α-1. Α-D-glucopyranosyl α-D-glucopyrano Seed. It is sweet and tastes good when drinking, and stabilizes the pH.
또한, 상기 레몬그라스액은 레몬그라스(Lemongrass)를 우려낸 액으로, 레몬그라스는 호흡기 감염증에 특히 효과가 있으며, 두통과 피로도를 경감시켜 주는 특징이 있다.In addition, the lemongrass solution is a solution of lemongrass (Lemongrass), lemongrass is particularly effective in respiratory infections, it is characterized by reducing headache and fatigue.
이하, 실시예에 대하여 설명한다.Hereinafter, an Example is described.
[실시예 1]Example 1
음료액 150㎖를 기준으로, 석창포 추출액 12㎖와, 오갈피 추출액 14㎖와, 엉겅퀴 추출액 12㎖와, 오미자 추출액 8㎖와, 매실 농축액 0.1㎖와, 산수유 추출액 12㎖와, 구기자 추출액 14㎖와, 설탕 18g 및 나머지 물로 시료 1을 만들었다.Based on 150 ml of the beverage, 12 ml of spearmint extract, 14 ml of this extract, 12 ml of thistle extract, 12 ml of thistle extract, 8 ml of Schizandra chinensis extract, 0.1 ml of Plum Concentrate, 12 ml of Cornus extract, 14 ml of Goji extract, Sample 1 was made with 18 g of sugar and the remaining water.
[실시예 2]Example 2
음료액 150㎖를 기준으로, 석창포 추출액 12㎖와, 오갈피 추출액 14㎖와, 엉겅퀴 추출액 12㎖와, 오미자 추출액 8㎖와, 매실 농축액 0.1㎖와, 산수유 추출액 12㎖와, 구기자 추출액 14㎖와, 설탕 18g과, 신선초즙 3㎖와, 끄라차이담 추출액 3㎖와, 트레할로스 수용액 2㎖와, 레몬그라스액 1.5㎖ 및 나머지 물로 시료 2를 만들었다.Based on 150 ml of the beverage, 12 ml of spearmint extract, 14 ml of this extract, 12 ml of thistle extract, 12 ml of thistle extract, 8 ml of Schizandra chinensis extract, 0.1 ml of Plum Concentrate, 12 ml of Cornus extract, 14 ml of Goji extract, Sample 2 was prepared from 18 g of sugar, 3 ml of fresh vinegar juice, 3 ml of Kratchaidam extract, 2 ml of trehalose aqueous solution, 1.5 ml of lemongrass solution and the remaining water.
[비교예 1]Comparative Example 1
음료액 150㎖를 기준으로, 석창포 추출액 6㎖와, 오갈피 추출액 7㎖와, 엉겅퀴 추출액 5㎖와, 오미자 추출액 4㎖와, 매실 농축액 0.05㎖와, 산수유 추출액 7㎖와, 구기자 추출액 5㎖와, 설탕 18g 및 나머지 물로 비교시료 1을 만들었다.On the basis of 150 ml of the beverage, 6 ml of Seokchangpo extract, 7 ml of Oggalpi extract, 5 ml of thistle extract, 4 ml of Schisandra chinensis extract, 0.05 ml of Plum Concentrate, 7 ml of Cornus extract, 5 ml of Goji extract, Comparative Sample 1 was prepared from 18 g of sugar and the remaining water.
[비교예 2]Comparative Example 2
음료액 150㎖를 기준으로, 석창포 추출액 18㎖와, 오갈피 추출액 17㎖와, 엉겅퀴 추출액 18㎖와, 오미자 추출액 16㎖와, 매실 농축액 0.05㎖와, 산수유 추출액 15㎖와, 구기자 추출액 17㎖와, 설탕 18g 및 나머지 물로 비교시료 2를 만들었다.Based on 150 ml of the beverage, 18 ml of spearmint extract, 17 ml of this extract, 18 ml of thistle extract, 16 ml of Schisandra chinensis extract, 0.05 ml of Plum Concentrate, 15 ml of Cornus extract, 17 ml of Goji extract, Comparative Sample 2 was made with 18 g of sugar and the remaining water.
그리고, 이들 시료에 대해 가용성 고형분, pH, 색도, 폴리페놀 함량, 플라보노이드 함량, 항산화 활성도를 확인하였다.And soluble solids, pH, chromaticity, polyphenol content, flavonoid content, antioxidant activity was confirmed for these samples.
이때, 모든 실험은 3회 반복하여 측정한 값으로 평균과 표준편차를 구하였으며, 실험 데이터의 통계 부석은 SPSS 프로그램(version SPSS 23.0)을 이용하여 분산분석을 실시하여 유의차가 인정되는 항목을 던컨의 다중 범위 비교(Duncan's multiple range test)으로 5%(p<0.05) 수준에서 각 처리구별로 유의성을 검증하였다.At this time, all experiments were repeated three times, and the average and standard deviation were calculated.The statistical analysis of experimental data was carried out using the SPSS program (version SPSS 23.0) to analyze the variance. Duncan's multiple range test examined the significance of each treatment at 5% ( p <0.05).
아울러, 정확한 분석을 위해 상기 시료들을 회전감압농축기(VV2011, Heidolph, Germany)를 이용하여 60℃에서 1시간 동안 감압 농축하였고, 이 농축액을 실험 대상으로 하였다.In addition, the samples were concentrated under reduced pressure at 60 ° C. for 1 hour using a rotary vacuum concentrator (VV2011, Heidolph, Germany) for accurate analysis.
먼저, 가용성 고형분 분석은 refractometer(HI 96801, Hanna Instruments Inc., USA)를 이용하여 Brix로 나타내었다.First, soluble solids analysis was expressed in Brix using a refractometer (HI 96801, Hanna Instruments Inc., USA).
그리고, pH는 pH 측정기(EF-7732, Istek, Seoul, Korea)를 이용하여 측정하였다.And, pH was measured using a pH meter (EF-7732, Istek, Seoul, Korea).
아울러, 폴리페놀 함량은 각 시료 0.25 ml에 10% Folin-Ciocalteu 시약 1.75 ml를 넣고 섞은 다음 7.5% Na2CO3를 0.3 ml 가한 뒤 30분간 암소에서 반응시킨 후 반응액의 흡광도 값을 분광광도계(Optizen 2120UV, Mecasys, Seoul, Korea)로 725 nm 에서 측정하였으며, 표준물질로 갈릭산(Sigma Chemical Co., St. Louis, MO, USA)를 이용하여 검량선을 작성하였다.In addition, the polyphenol content was measured by adding 1.75 ml of 10% Folin-Ciocalteu reagent to 0.25 ml of each sample, adding 0.3 ml of 7.5% Na 2 CO 3 , and reacting in the dark for 30 minutes, and then measuring the absorbance of the reaction solution using a spectrophotometer ( Optizen 2120UV, Mecasys, Seoul, Korea) was measured at 725 nm, and a calibration curve was prepared using gallic acid (Sigma Chemical Co., St. Louis, MO, USA) as a standard.
뿐만 아니라, 플라보노이드 함량은 각 시료 1 ml와 증류수 4 ml를 혼합 후 5% NaNO2를 0.3 ml를 가한 뒤 5분간 반응시킨 후 10% AlCl3를 0.3 ml를 가한 후 6분간 방치한 다음, 2 ml의 1M NaOH를 가한 후 반응액의 흡광도 값을 분광광도계(Optizen 2120UV, Mecasys, Seoul, Korea)로 510 nm 에서 측정하였으며, 표준물질로 카테킨(Sigma Chemical Co., St. Louis, MO, USA)를 이용하여 검량선을 작성하였다.In addition, the flavonoid content was mixed with 1 ml of each sample and 4 ml of distilled water, and then reacted for 5 minutes after adding 0.3 ml of 5% NaNO 2 , and then allowed to stand for 6 minutes after adding 0.3 ml of 10% AlCl 3 , followed by 2 ml Absorbance value of the reaction solution was measured at 510 nm with a spectrophotometer (Optizen 2120UV, Mecasys, Seoul, Korea) and catechin (Sigma Chemical Co., St. Louis, MO, USA) was used as a standard. An analytical curve was prepared.
나아가, 항산화 활성(DPPH free radical scavenging activity) 정도는 각 시료 50㎕와 증류수 950㎕를 혼합 후 100㎕ DPPH solution을 가한 뒤 암소에서 30분간 반응시킨 후 반응액의 흡광도 값을 분광광도계(Optizen 2120UV, Mecasys, Seoul, Korea)로 517 nm에서 측정하였으며, 산출식은 아래와 같다.Furthermore, the degree of antioxidant activity (DPPH free radical scavenging activity) was mixed with 50 μl of each sample and 950 μl of distilled water, followed by 100 μl DPPH solution, and reacted in the dark for 30 minutes. The absorbance of the reaction solution was measured using a spectrophotometer (Optizen 2120UV, Mecasys, Seoul, Korea) was measured at 517 nm, the calculation is as follows.
(산출식)(Calculation type)
마지막으로, 맛과 향취 등에 대한 관능평가를 위해 실험에 대한 관심도와 적합성이 인정된 전남대학교 식품공학과 학부대학원생 50명을 대상으로 관능검사를 실시하였다.Lastly, for sensory evaluation of taste and odor, sensory tests were conducted on 50 graduate students of the Faculty of Food Science and Technology, Chonnam National University.
이때, 평가원들에게 평가목적과 평가방법 등을 상세히 설명한 후 7점 기호 척도법에 따라 실시 평가 항목은 단맛, 신맛, 쓴맛, 떫은 맛, 색, 향미 및 전체적인 기호도의 항목으로 구성되었으며, 각 항목에 대하여 1점에서 7점까지 점수를 직접 기입하게 하였다(7:대단히 좋다, 6:보통으로 좋다, 5:약간 좋다, 4:좋지도 싫지도 않다, 3:약간 싫다, 2:보통으로 싫다, 1:대단히 싫다).At this time, the purpose of evaluation and evaluation methods were explained to the evaluators in detail, and the evaluation items carried out according to the 7-point symbol scale method consisted of items of sweetness, sourness, bitterness, astringent taste, color, flavor and overall preference degree. (1: Very good, 6: Normally good, 5: Slightly good, 4: Not good or not, 3: Slightly disliked, 2: Usually disliked, 1: I hate it very much).
실험 결과, 가용성 고형분은 시료1,2 및 비교시료1,2 순으로 각각 67.73 Brix, 68.92 Brix, 57.04 Brix, 67.82 Brix를 나타내었는데, 적어도 60 Brix 이상을 유지해야 하므로 시료1,2 및 비교시료2는 만족했으나 비교시료1은 미달하였다.As a result, the soluble solids showed 67.73 Brix, 68.92 Brix, 57.04 Brix, and 67.82 Brix in the order of Samples 1 and 2 and Comparative Samples 1 and 2, respectively. Was satisfactory, but comparative sample 1 was insufficient.
또한, pH는 3.20-3.30을 유지하여야 하는데, 각각 3.24, 3.30, 3.17, 3.41로 나타나 시료1,2는 만족하였으나, 비교시료1,2는 만족하지 못하였다.In addition, pH should be maintained at 3.20-3.30, which is 3.24, 3.30, 3.17, and 3.41, respectively, indicating that Samples 1 and 2 were satisfied, but Comparative Samples 1 and 2 were not satisfied.
그리고, 폴리페놀 함량은 각각 292.41㎍/㎖, 303.54㎍/㎖, 216.80㎍/㎖, 289.04㎍/㎖로서 시료1,2가 비교시료1,2에 비해 훨씬 높게 나타났다.The polyphenol contents were 292.41 µg / ml, 303.54 µg / ml, 216.80 µg / ml, and 289.04 µg / ml, respectively, and samples 1 and 2 were much higher than the comparative samples 1,2.
또한, 플라보노이드 함량은 각각 112.24㎍/㎖, 122.41㎍/㎖, 82.47㎍/㎖, 103.64㎍/㎖로서 이또한 시료1,2가 비교시료1,2에 비해 훨씬 높게 나타났다.In addition, the flavonoid contents were 112.24 µg / ml, 122.41 µg / ml, 82.47 µg / ml, and 103.64 µg / ml, respectively, and samples 1 and 2 were much higher than those of the comparative samples 1,2.
또한, 항산화 활성은 각각 5.35%, 5.37%, 4.21%, 4.80%로 나타나 시료1,2가 비교시료1,2에 비해 항산화성이 훨씬 우수한 것으로 확인되었다.In addition, the antioxidant activity was 5.35%, 5.37%, 4.21%, 4.80%, respectively, it was confirmed that the samples 1 and 2 were much better than the comparative samples 1 and 2.
마지막으로, 관능평가는 음용자의 기호도를 평가하기 위한 것으로 표준편차를 이용하여 수치적으로 표시하였는 바, 5 이상은 식음하기에 적당하고 좋지만, 5 미만은 식음하기에 적당치 않은 것으로 판별하였다.Finally, the sensory evaluation was to evaluate the preference of the drinker, and numerically expressed by using the standard deviation, it was determined that more than 5 is suitable for food and drinking, but less than 5 is not suitable for food and beverage.
평가결과, 각각 5.52, 5.48, 3.75, 3.83으로 나타났다. 따라서, 시료1,2가 먹기에도 좋은 것으로 확인되었다.The evaluation result was 5.52, 5.48, 3.75, and 3.83, respectively. Therefore, it was confirmed that Samples 1 and 2 are also good to eat.
Claims (4)
음료액 150㎖를 기준으로,
석창포 추출액 12㎖와, 오갈피 추출액 14㎖와, 엉겅퀴 추출액 12㎖와, 오미자 추출액 8㎖와, 매실 농축액 0.1㎖와, 산수유 추출액 12㎖와, 구기자 추출액 14㎖와, 설탕 18g과, 신선초즙 3㎖와, 끄라차이담 추출액 3㎖와, 트레할로스 수용액 2㎖와, 레몬그라스액 1.5㎖ 및 나머지 물로 이루어진 것을 특징으로 하고,
상기 석창포 추출액은 석창포의 생잎, 생줄기 및 꽃을 항아리에 넣고, 검은콩을 함께 넣은 상태에서 중탕하여 추출된 것을 특징으로 하는 에너지 음료액.
In energy drinks,
Based on 150 ml of liquid,
12 ml of Seokchangpo extract, 14 ml of Oggalpi extract, 12 ml of thistle extract, 8 ml of Schisandra chinensis extract, 0.1 ml of Plum Concentrate, 12 ml of Cornus extract, 14 ml of Goji extract, 18 g of Sugar, 3 ml of fresh vinegar juice Wada, characterized in that consisting of 3 ml of the Kratchaidam extract, 2 ml of trehalose aqueous solution, 1.5 ml of lemongrass solution and the remaining water,
The changchangpo extract is an energy drink liquid, characterized in that the raw leaves, raw stems and flowers of the changchangpo in a jar, extracted by hot water in a state that put black beans together.
상기 물은 증류수를 활성 모데나이트 25중량%와, 마그네슘 4중량%와, 이방성 희토류 자석분말 10중량%와, 케나프 숯 1.5중량% 및 나머지 천연 모데나이트로 이루어진 여과재에 여과시킨 것임을 특징으로 하는 에너지 음료액.The method according to claim 1,
The water is energy characterized in that the distilled water is filtered through a filter medium consisting of 25% by weight of active mordenite, 4% by weight of magnesium, 10% by weight of anisotropic rare earth magnet powder, 1.5% by weight of kenaf charcoal and the remaining natural mordenite Beverages.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020170150478A KR102045192B1 (en) | 2017-11-13 | 2017-11-13 | Energy drink liquid |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020170150478A KR102045192B1 (en) | 2017-11-13 | 2017-11-13 | Energy drink liquid |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20190054333A KR20190054333A (en) | 2019-05-22 |
KR102045192B1 true KR102045192B1 (en) | 2019-11-14 |
Family
ID=66679657
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020170150478A KR102045192B1 (en) | 2017-11-13 | 2017-11-13 | Energy drink liquid |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR102045192B1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20210109074A (en) | 2020-02-26 | 2021-09-06 | 경남대학교 산학협력단 | Food Composition Comprising Extract of Paullinia cupana, Vitamin and Natural Extract as an Active Ingredients |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20240083287A (en) | 2022-12-02 | 2024-06-12 | 몸엔용바이오 농업회사법인 주식회사 | Method for manufacturing sports beverage containing antler and sports beverage produced therefrom |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101267509B1 (en) * | 2012-12-03 | 2013-05-27 | (주)맥스파워이앤디 | Method for manufacturing multi-functional energy drink and multi-functional energy drink manufactured thereby |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20050103742A (en) * | 2004-04-27 | 2005-11-01 | (주) 워터앤 닥터 | Handy filter for creation of alkaliwater and manufacturing method there of resolve |
KR100637700B1 (en) * | 2004-05-14 | 2006-10-25 | 한종현 | Drink produced by using medicinal herbs with a usage as recovery of exhaustion |
KR100913448B1 (en) * | 2007-07-27 | 2009-08-25 | 목포대학교산학협력단 | Tea using Acorus gramineus leaf and method thereof |
KR101541638B1 (en) | 2014-01-06 | 2015-08-03 | 동의대학교 산학협력단 | Energy drink composition comprising fruits and vegetables extracts |
-
2017
- 2017-11-13 KR KR1020170150478A patent/KR102045192B1/en active IP Right Grant
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101267509B1 (en) * | 2012-12-03 | 2013-05-27 | (주)맥스파워이앤디 | Method for manufacturing multi-functional energy drink and multi-functional energy drink manufactured thereby |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20210109074A (en) | 2020-02-26 | 2021-09-06 | 경남대학교 산학협력단 | Food Composition Comprising Extract of Paullinia cupana, Vitamin and Natural Extract as an Active Ingredients |
Also Published As
Publication number | Publication date |
---|---|
KR20190054333A (en) | 2019-05-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101101759B1 (en) | The manufacturing method of beverage having eliminatory effect of Ethanol-Induced Hangover and containing persimmon vinegar etc, and the beverage | |
CN105341570A (en) | Series Clinacanthus nutans functional beverage and preparation method thereof | |
KR20140103622A (en) | The method for manufacturing functional tea product made from onion skin, and the product made by the method | |
CN102599592A (en) | Roselle beverage | |
EP3264919A1 (en) | Composition, drink, method of production and use thereof | |
KR102045192B1 (en) | Energy drink liquid | |
CN104472984B (en) | The preparation method and its product of high sugar rose magma | |
CN105558056A (en) | Inonotus obliquus milk tea powder and preparation method thereof | |
RU2612779C2 (en) | Beverage concentrate (versions) | |
CN108925793A (en) | Sugar-free emblic dry fruit beverage and preparation method thereof | |
Joshi et al. | Studies on physico-chemical properties of noni fruit (Morinda citrifolia) and preparation of noni beverages | |
CN101322514A (en) | Green tea Ganoderma lucidum drink and preparation method thereof | |
KR20010110831A (en) | Manufacture method and tea for alcohol remove | |
CN104489853B (en) | A kind of preparation method alcoholic liver injury to the soda of protective effect | |
KR100930910B1 (en) | Beverage containing fresh Schisandra chinensis liquid and its manufacturing method | |
KR100848706B1 (en) | Nearwater beverage containing herb | |
KR100506955B1 (en) | Manufacturing method of sesame extracted composition | |
CN105475792B (en) | A water-retaining beverage prepared from herba Typhae and flos Chrysanthemi and mineral water, and its preparation method | |
CN109619232A (en) | Banana aldehyde tea bottom and preparation method | |
WO2002091845A1 (en) | Lingering intoxication aquaous tea comprising puerh extract as an effective component and process for preparation thereof | |
RU2765133C1 (en) | Tea composition | |
CN108925794A (en) | Low sugar beverage of Phyllanthus emblica and preparation method thereof | |
CN102550921A (en) | Preparation method of grape seed polyphenol oral liquid | |
KR102055300B1 (en) | Liquid composition for health functional beverage | |
KR102104772B1 (en) | Health functional food comprising crude drugs |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant |